ARDELYX, INC. (ARDX) reporting calendar
ARDELYX, INC. files periodic reports with the SEC as ARDX on Nasdaq. Atlas tracks 43 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 21 Jul 2026 – 10 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 30 Apr 2026
- Reports on record
- 43
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 31 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open ARDX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 30 Apr 2026 | 30 days | 0001437402-26-000022 |
| 10-K | 31 Dec 2025 | 19 Feb 2026 | 50 days | 0001437402-26-000013 |
| 10-Q | 30 Sep 2025 | 30 Oct 2025 | 30 days | 0001437402-25-000018 |
| 10-Q | 30 Jun 2025 | 4 Aug 2025 | 35 days | 0001628280-25-037464 |
| 10-Q | 31 Mar 2025 | 1 May 2025 | 31 days | 0001628280-25-021516 |
| 10-K | 31 Dec 2024 | 20 Feb 2025 | 51 days | 0001628280-25-006653 |
| 10-Q | 30 Sep 2024 | 31 Oct 2024 | 31 days | 0001628280-24-044551 |
| 10-Q | 30 Jun 2024 | 1 Aug 2024 | 32 days | 0001628280-24-034121 |
| 10-Q | 31 Mar 2024 | 2 May 2024 | 32 days | 0001628280-24-019990 |
| 10-K | 31 Dec 2023 | 22 Feb 2024 | 53 days | 0001628280-24-006393 |
| 10-Q | 30 Sep 2023 | 31 Oct 2023 | 31 days | 0001628280-23-035597 |
| 10-Q | 30 Jun 2023 | 2 Aug 2023 | 33 days | 0001628280-23-026569 |
| 10-Q | 31 Mar 2023 | 3 May 2023 | 33 days | 0001628280-23-015212 |
| 10-K | 31 Dec 2022 | 2 Mar 2023 | 61 days | 0001628280-23-006041 |
| 10-Q | 30 Sep 2022 | 3 Nov 2022 | 34 days | 0001628280-22-028180 |
| 10-Q | 30 Jun 2022 | 4 Aug 2022 | 35 days | 0001628280-22-021047 |
| 10-Q | 31 Mar 2022 | 5 May 2022 | 35 days | 0001628280-22-012630 |
| 10-K | 31 Dec 2021 | 28 Feb 2022 | 59 days | 0001628280-22-004226 |
| 10-Q | 30 Sep 2021 | 12 Nov 2021 | 43 days | 0001628280-21-022978 |
| 10-Q | 30 Jun 2021 | 13 Aug 2021 | 44 days | 0001628280-21-016912 |
| 10-Q | 31 Mar 2021 | 6 May 2021 | 36 days | 0001628280-21-009180 |
| 10-K | 31 Dec 2020 | 8 Mar 2021 | 67 days | 0001558370-21-002500 |
| 10-Q | 30 Sep 2020 | 5 Nov 2020 | 36 days | 0001558370-20-012720 |
| 10-Q | 30 Jun 2020 | 6 Aug 2020 | 37 days | 0001558370-20-009636 |
| 10-Q | 31 Mar 2020 | 7 May 2020 | 37 days | 0001558370-20-005688 |
| 10-K | 31 Dec 2019 | 6 Mar 2020 | 66 days | 0001558370-20-002138 |
| 10-Q | 30 Sep 2019 | 6 Nov 2019 | 37 days | 0001558370-19-010174 |
| 10-Q | 30 Jun 2019 | 9 Aug 2019 | 40 days | 0001558370-19-007809 |
| 10-Q | 31 Mar 2019 | 7 May 2019 | 37 days | 0001558370-19-004249 |
| 10-K | 31 Dec 2018 | 6 Mar 2019 | 65 days | 0001558370-19-001583 |
| 10-Q | 30 Sep 2018 | 7 Nov 2018 | 38 days | 0001558370-18-008786 |
| 10-Q | 30 Jun 2018 | 7 Aug 2018 | 38 days | 0001558370-18-006606 |
| 10-Q | 31 Mar 2018 | 8 May 2018 | 38 days | 0001558370-18-004307 |
| 10-K | 31 Dec 2017 | 14 Mar 2018 | 73 days | 0001558370-18-002056 |
| 10-Q | 30 Sep 2017 | 7 Nov 2017 | 38 days | 0001193125-17-334997 |
| 10-Q | 30 Jun 2017 | 9 Aug 2017 | 40 days | 0001193125-17-252121 |
| 10-Q | 31 Mar 2017 | 5 May 2017 | 35 days | 0001193125-17-159933 |
| 10-K | 31 Dec 2016 | 17 Feb 2017 | 48 days | 0001193125-17-047972 |
| 10-Q | 30 Sep 2016 | 7 Nov 2016 | 38 days | 0001193125-16-761639 |
| 10-Q | 30 Jun 2016 | 8 Aug 2016 | 39 days | 0001193125-16-675135 |
Source: SEC EDGAR company submissions for CIK 0001437402. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.